Top compounds associated with response to ALKBH8


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.084 0.02
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.074 0.03
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.079 0.03
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.03
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC 0.074 0.03
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.071 0.03
mRNA manumycin A CTRPv2 pan-cancer AAC 0.07 0.03
Download CSV